Functional Pharmaceuticals is developing potential compounds that could diagnose and treat Alzheimer's disease (AD). The compounds also show promise as possible diagnostic tools for detecting the presence of the amyloid plaques characteristic of this crippling neurodegenerative disease.

Currently, there is no approved test to diagnose AD.